MEDEL FOR PROFYLAKTISK OCH TERAPEUTISK BEHANDLING AV PROSTATAHYPERPLASI PA BASIS AV EN BLANDNING AV VISS ANTIOSTROGEN OCH VISS ANTIGONADOTROPT VERKANDE ANTIANDROGEN

摘要

A pharmaceutical composition comprising an anti-estrogen and an antigonadotropically effective anti-androgen, e.g., in a weight ratio of anti-estrogen to anti-androgen of essentially 2:1 to 1:10 is effective for the prophylaxis and therapy of prostate hyperplasia. Suitable anti-estrogens include, for example, tamoxifen. Antigonadotropically active anti-androgens preferably are steroids having anti-androgenic and progestational properties, e.g., cyproterone acetate.